Roberta Schmieder

1.2k total citations
8 papers, 433 citations indexed

About

Roberta Schmieder is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Roberta Schmieder has authored 8 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Roberta Schmieder's work include Cancer Mechanisms and Therapy (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Roberta Schmieder is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Roberta Schmieder collaborates with scholars based in Germany, United States and Belgium. Roberta Schmieder's co-authors include Ilaria Elia, Stefan Christen, Sarah‐Maria Fendt, Doriane Lorendeau, Arne Scholz, Joerg M. Buescher, Martin F. Orth, Kristine L. Metzger, Koen Veys and Shawn M. Davidson and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Cell Reports.

In The Last Decade

Roberta Schmieder

6 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Schmieder Germany	5	252	221	143	54	48	8	433
Maria Apicella Italy	6	274 1.1×	191 0.9×	158 1.1×	83 1.5×	22 0.5×	6	446
Noélia Che China	7	282 1.1×	167 0.8×	103 0.7×	44 0.8×	82 1.7×	10	424
Xuening Ji China	9	347 1.4×	209 0.9×	199 1.4×	59 1.1×	104 2.2×	16	618
Yanqing Wu China	10	428 1.7×	318 1.4×	111 0.8×	57 1.1×	46 1.0×	16	572
Petra Koudelková Austria	5	368 1.5×	225 1.0×	191 1.3×	77 1.4×	121 2.5×	6	593
Jingsun Wei China	9	192 0.8×	145 0.7×	103 0.7×	77 1.4×	20 0.4×	22	394
Yuchao He China	12	393 1.6×	303 1.4×	112 0.8×	121 2.2×	40 0.8×	25	593
Jason T. Godfrey United States	4	224 0.9×	100 0.5×	153 1.1×	106 2.0×	53 1.1×	5	404
Alice Lallo United Kingdom	8	215 0.9×	200 0.9×	348 2.4×	133 2.5×	21 0.4×	10	489
Ninghua Yao China	13	331 1.3×	266 1.2×	117 0.8×	79 1.5×	47 1.0×	43	516

Countries citing papers authored by Roberta Schmieder

Since Specialization

Citations

This map shows the geographic impact of Roberta Schmieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Schmieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Schmieder more than expected).

Fields of papers citing papers by Roberta Schmieder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Schmieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Schmieder. The network helps show where Roberta Schmieder may publish in the future.

Co-authorship network of co-authors of Roberta Schmieder

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Schmieder. A scholar is included among the top collaborators of Roberta Schmieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Schmieder. Roberta Schmieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Christen, Stefan, Doriane Lorendeau, Roberta Schmieder, et al.. (2016). Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis. Cell Reports. 17(3). 837–848. 185 indexed citations

Elia, Ilaria, Roberta Schmieder, Stefan Christen, & Sarah‐Maria Fendt. (2015). Organ-Specific Cancer Metabolism and Its Potential for Therapy. Handbook of experimental pharmacology. 233. 321–353. 89 indexed citations

Schmieder, Roberta, Florian Puehler, Roland Neuhaus, et al.. (2013). Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma. Neoplasia. 15(10). 1161–IN24. 51 indexed citations

Schmieder, Roberta, Jens Hoffmann, Michael W. Becker, et al.. (2013). Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer. International Journal of Cancer. 135(6). 1487–1496. 103 indexed citations

Schmieder, Roberta, Peter Ellinghaus, Arne Scholz, et al.. (2012). Abstract 2337: Regorafenib (BAY 73-4506): Anti-metastatic activity in a mouse model of colorectal cancer. Cancer Research. 72(8_Supplement). 2337–2337. 4 indexed citations

Schmieder, Roberta, Florian Puehler, Roland Neuhaus, et al.. (2011). Abstract B247: The MEK inhibitor BAY 869766 inhibits tumor growth and metastatic spread, prolongs the survival and acts synergistically with standard of care drugs in models of hepatocellular carcinoma and pancreatic cancer.. Molecular Cancer Therapeutics. 10(11_Supplement). B247–B247.

Puehler, Florian, Maria Kissel, Alex A. Adjei, et al.. (2010). 151 Allosteric MEK inhibitor BAY 86-9766 (RDEA119) shows anti-tumor efficacy in mono-and combination therapy in preclinical models of hepatocellular carcinoma and pancreatic cancer. European Journal of Cancer Supplements. 8(7). 53–53.

Bierhoff, E., et al.. (2008). Herzbeteiligung bei Non-Hodgkin-Lymphomen. DMW - Deutsche Medizinische Wochenschrift. 116(13). 491–495. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact